Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation

NCT01643668 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
Myelodysplastic Syndrome

Interventions

DRUG: Busulfan
DRUG: Clofarabine
PROCEDURE: Allogeneic Stem Cell Infusion

Sponsor

Massachusetts General Hospital